HOXD-AS1: a novel oncogenic long intergenic non-coding RNA in humans.
CONCLUSIONS: HOXD-AS1 may be a prognostic biomarker and potential therapeutic target for various tumor diagnosis and treatment.
PMID: 31002165 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Epithelial Cancer | Genetics | Stem Cell Therapy | Stem Cells